| |
Boletim Científico Diário
 |
 Expand+ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention
Stefanie Schulz1,*, Julinda Mehilli1, Franz-Josef Neumann2, Tibor Schuster3, Steffen Massberg1, Christian Valina2, Melchior Seyfarth1, Jürgen Pache1, Karl-Ludwig Laugwitz4, Hans-Joachim Büttner2, Gjin Ndrepepa1, Albert Schömig1,4 and Adnan Kastrati1 for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 3A Trial Investigators
Abstract - clique aqui
|
Expand+COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial
Massimo Imazio1,*, Rita Trinchero1, Antonio Brucato2, Maria Elena Rovere3, Anna Gandino4, Roberto Cemin5, Stefania Ferrua6, Silvia Maestroni2, Edoardo Zingarelli3, Alberto Barosi4, Caterina Simon2, Fabrizio Sansone3, Davide Patrini4,†, Ettore Vitali4,†, Paolo Ferrazzi2, David H. Spodick7, Yehuda Adler8 and on behalf of the COPPS Investigators
Abstract - clique aqui
|
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function. Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Stefan James MD, PhD*, Andrzej Budaj MD, PhD, Philip Aylward MD, PhD, Kristen K. Buck MD, Christopher P. Cannon MD, Jan H. Cornel MD, PhD, Robert A. Harrington MD, Jay Horrow MD, Hugo Katus MD, PhD, Matyas Keltai MD, PhD, Basil S. Lewis MD, PhD, Keyur Parikh MD, Robert F. Storey MD, PhD, Karolina Szummer MD, PhD, Daniel Wojdyla MSc, and Lars Wallentin MD, PhD
Abstract - clique aqui
|
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt, MD, MPH; Kim A. Eagle, MD; E. Magnus Ohman, MD; Alan T. Hirsch, MD; Shinya Goto, MD, PhD; Elizabeth M. Mahoney, ScD; Peter W. F. Wilson, MD; Mark J. Alberts, MD; Ralph D’Agostino, PhD; Chiau-Suong Liau, MD, PhD; Jean-Louis Mas, MD; Joachim Röther, MD; Sidney C. Smith Jr, MD; Geneviève Salette, PharmD, MSc; Charles F. Contant, PhD; Joseph M. Massaro, PhD; Ph. Gabriel Steg, MD; for the REACH Registry Investigators
Abstract - clique aqui
|
|
 |
|
|
|
Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults
Zhao, Guixiang; Ford, Earl S; Li, Chaoyang; Kris-Etherton, Penny M; Etherton, Terry D; Balluz, Lina S
Abstract - clique aqui
|
Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients
Maurizio Averna, MDa, Augusto Zaninelli, MDb, Cristina Le Grazie, MDc, Gian Franco Gensini, MDb
Abstract - clique aqui
|
Cardiac safety profile of rosiglitazone: A comprehensive meta-analysis of randomized clinical trials
Edoardo Mannuccia, Matteo Monamia, Mauro Di Baria, Caterina Lamannaa, Francesca Goria, Gian Franco Gensinib, Niccolò Marchionnia
Abstract - clique aqui
|
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: Data from the EUROTRANSFER registry
Artur Dziewierza, Zbigniew Siudaka, Tomasz Rakowskia, Micha³ Chyrchelb, Waldemar Mieleckia, Magnus Janzonc, Ralf Birkemeyerd, Ilkka Tieralae, Roman M. Wojdy³ab, Jacek S. Dubiela, Dariusz Dudekb
Abstract - clique aqui
|
Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II). A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease
Whady Hueb MD, PhD*, Neuza Lopes MD, PhD, Bernard J. Gersh MB, ChB, DPhil, Paulo R. Soares MD, PhD, Expedito E. Ribeiro MD, PhD, Alexandre C. Pereira MD, PhD, Desiderio Favarato MD, PhD, Antonio Sérgio C. Rocha MD, Alexandre C. Hueb MD, PhD, and Jose A.F. Ramires MD, PhD
Abstract - clique aqui
|
Nesiritide in Acute Decompensated Heart Failure: A Pooled Analysis of Randomized Controlled Trials
William T. Abraham MD1,*, Robin J. Trupp PhD, APRN2, David Jarjoura PhD3
Abstract - clique aqui
|
Dietary intake of stearidonic acid–enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety1,2,3
Shawna L Lemke, John L Vicini, Hong Su, Daniel A Goldstein, Margaret A Nemeth, Elaine S Krul and William S Harris
Abstract - clique aqui
|
The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better
Peters, M. J. L.1; Voskuyl, A. E.1; Sattar, N.2; Dijkmans, B. A. C.1; Smulders, Y. M.3; Nurmohamed, M. T.
Abstract - clique aqui
|
Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity
Klein, Inge HHT; Abrahams, Alferso C; van Ede, Thomas; Oey, P Liam; Ligtenberg, Gerry; Blankestijn, Peter J
Abstract - clique aqui
|
The consequences of applying NICE chest pain guidelines to an acute medical population: a role for cardiac computed tomography
C. Patterson1, L. Bryan1, E. Nicol2, M. Duncan3, D. Bell4 and S. Padley1
Abstract - clique aqui
|
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James1,*, Dominick J. Angiolillo2, Jan H. Cornel3, David Erlinge4, Steen Husted5, Frederic Kontny6, Juan Maya7, Josë C. Nicolau8, Jindrich Spinar9, Robert F. Storey10, Susanna R. Stevens11 and Lars Wallentin1 for the PLATO study group
Abstract - clique aqui
|
Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart
Myung-A. Kim, MD12, Dongheon Yang, MD, PhD23, Keisuke Kida, MD, PhD24, Natalia Molotkova, PhD2, Seon Ju Yeo, PhD2, Nissi Varki, NM5, Michikado Iwata, MD2, Nancy D. Dalton, RDCS2, Kirk L. Peterson, MD2, Wolf-Eberhard Siems, PhD6, Thomas Walther, PhD78, Randy T. Cowling, PhD2, John Kjekshus, MD, PhD29, Barry Greenberg, MD2
Abstract - clique aqui
|
Utility of Daily Diuretic Orders for Identifying Acute Decompensated Heart Failure Patients for Quality Improvement
Campbell, Patrick T. MD; Tremaglio, Joseph MD; Bhardwaj, Adarsh MD; Ryan, Jason MD, MPH
Abstract - clique aqui
|
Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes
Jian Yang1,†, Lifang Yang2,†, Yi Wan3,†, Jian Zuo1,†, Jun Zhang4,†, Wensheng Chen1,†, Jun Li4, Lijun Sun5, Shiqiang Yu1, Jincheng Liu1, Tao Chen1, Weixun Duan1, Lize Xiong2,* and Dinghua Yi1,*
Abstract - clique aqui
|
Thyroid hormone metabolism in heart failure: iodothyronine deiodinases in focus
Olivares, Emerson L; Carvalho, Denise P
Abstract - clique aqui
|
Effect of an Implantable Gentamicin-Collagen Sponge on Sternal Wound Infections Following Cardiac Surgery
Elliott Bennett-Guerrero, MD; T. Bruce Ferguson Jr, MD; Min Lin, PhD; Jyotsna Garg, MS; Daniel B. Mark, MD, MPH; Vincent A. Scavo Jr, MD; Nicholas Kouchoukos, MD; John B. Richardson Jr, MD; Renee L. Pridgen, BS; G. R. Corey, MD; for the SWIPE-1 Trial Group
Abstract - clique aqui
|
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Prof Karl Swedberg MD a , Prof Michel Komajda MD b, Prof Michael Böhm MD c, Prof Jeffrey S Borer MD d, Prof Ian Ford PhD e, Ariane Dubost-Brama MD f, Guy Lerebours MD f, Prof Luigi Tavazzi MD g, on behalf of the SHIFT Investigators‡
Abstract - clique aqui
|
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Prof Lars Wallentin MD a , Prof Salim Yusuf DPhil b, Prof Michael D Ezekowitz MD c, Marco Alings MD d, Marcus Flather MD e, Maria Grazia Franzosi PhD f, Prof Prem Pais MD g, Prof Antonio Dans MD h, John Eikelboom MD b, Jonas Oldgren MD a, Janice Pogue PhD b, Paul A Reilly PhD i, Sean Yang MSc b, Prof Stuart J Connolly MD b, on behalf of the RE-LY investigators
Abstract - clique aqui
|
Plasma Renin Activity Predicts Blood Pressure Responses to â-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
Stephen T. Turner1, Gary L. Schwartz1, Arlene B. Chapman2, Amber L. Beitelshees3, John G. Gums4, Rhonda M. Cooper-DeHoff4, Eric Boerwinkle5, Julie A. Johnson4 and Kent R. Bailey1
Abstract - clique aqui
|
One single dose of histidine–tryptophan–ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized study
Bjørn Braathen, MDa, Anders Jeppsson, MD, PhDbc, Henrik Scherstén, MD, PhDbc, Ole M. Hagen, MDa, Øystein Vengen, MD, PhDa, Helena Rexius, MD, PhDbc, Vincenzo Lepore, MD, PhDbc, Theis Tønnessen, MD, PhDad
Abstract - clique aqui
|
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt, MD, MPH; Kim A. Eagle, MD; E. Magnus Ohman, MD; Alan T. Hirsch, MD; Shinya Goto, MD, PhD; Elizabeth M. Mahoney, ScD; Peter W. F. Wilson, MD; Mark J. Alberts, MD; Ralph D’Agostino, PhD; Chiau-Suong Liau, MD, PhD; Jean-Louis Mas, MD; Joachim Röther, MD; Sidney C. Smith Jr, MD; Geneviève Salette, PharmD, MSc; Charles F. Contant, PhD; Joseph M. Massaro, PhD; Ph. Gabriel Steg, MD; for the REACH Registry Investigators
Abstract - clique aqui
|
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function. Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Stefan James MD, PhD*, Andrzej Budaj MD, PhD, Philip Aylward MD, PhD, Kristen K. Buck MD, Christopher P. Cannon MD, Jan H. Cornel MD, PhD, Robert A. Harrington MD, Jay Horrow MD, Hugo Katus MD, PhD, Matyas Keltai MD, PhD, Basil S. Lewis MD, PhD, Keyur Parikh MD, Robert F. Storey MD, PhD, Karolina Szummer MD, PhD, Daniel Wojdyla MSc, and Lars Wallentin MD, PhD
Abstract - clique aqui
|
Expand+COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial
Massimo Imazio1,*, Rita Trinchero1, Antonio Brucato2, Maria Elena Rovere3, Anna Gandino4, Roberto Cemin5, Stefania Ferrua6, Silvia Maestroni2, Edoardo Zingarelli3, Alberto Barosi4, Caterina Simon2, Fabrizio Sansone3, Davide Patrini4,†, Ettore Vitali4,†, Paolo Ferrazzi2, David H. Spodick7, Yehuda Adler8 and on behalf of the COPPS Investigators
Abstract - clique aqui
|
Expand+ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention
Stefanie Schulz1,*, Julinda Mehilli1, Franz-Josef Neumann2, Tibor Schuster3, Steffen Massberg1, Christian Valina2, Melchior Seyfarth1, Jürgen Pache1, Karl-Ludwig Laugwitz4, Hans-Joachim Büttner2, Gjin Ndrepepa1, Albert Schömig1,4 and Adnan Kastrati1 for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 3A Trial Investigators
Abstract - clique aqui
|
|
|
|
|
|
|
| |
|
